Company / Capital Expenditures
LifeStance Health Group, Inc. Capital Expenditures History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$36.1M
FY2025
5-year range
$21.6M / $94.5M
FY2021-FY2025
Trend
+67.5%
vs FY2024
Sector context
#86 of 145
Health Care
What the data says
At $36M, LifeStance Health Group, Inc.'s capital expenditures ranks #86 of 145 in the Health Care sector. Capital Expenditures returned to growth in FY2025 after 3 years of decline, reaching $36M.
Based on SEC 10-K filings.
$36M in FY2025 with a 5-year CAGR of +7.4%.
Declined from $41M to $36M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -23.0%
- 5-Year CAGR
- +7.4%
- 10-Year CAGR
- -
Sector benchmark
#86 of 145 in Health CareTop 59% of 145This company $36.1M Sector average $268.6M
▼
-86.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.4%, indicating consistent growth.
- In FY2025, capital expenditures increased 67.5% year-over-year.
- Ranks #86 out of 145 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $36.1M | +67.5% |
| FY2024 | $21.6M | -46.8% |
| FY2023 | $40.5M | -48.9% |
| FY2022 | $79.3M | -16.1% |
| FY2021 | $94.5M | +274.0% |
| FY2020 | $25.3M | +76.5% |
| FY2019 | $14.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026